Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medivolve Inc MEDVF

Medivolve, Inc. is a Canada-based healthcare technology company. The Company has two business units: Medivolve Pharmacy Division (MPD) and Collection Sites Diagnostics (CSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine, and psychiatry to patients in Southern California. CSD’s software platform, Electronic Health Records app (EHR), is focused on supporting clinical staff, is a series of assets and functionalities that enhance the customer experience and provide an end-to-end lab solution. The Company, through its subsidiaries, Medivolve Pharmacy Inc., and Kedy Ying Jao D.O., a medical corporation, operate a distributed network of two retail patient-care locations in California, United States. The Company has served hundreds of thousands of patients across the United States and facilitated more than 1,533,000 clinical tests.


OTCPK:MEDVF - Post by User

Post by QuatrePommeson Feb 12, 2021 7:41am
964 Views
Post# 32549897

Please hear me out

Please hear me out

I'd really like to address a few things for even the 1 or 2 people who are willing to listen, look into what's going on, and come to their own conclusions. As to why I'm doing this, yes, I closed my position, but like I said yesterday, if you're sitting on public information that could inform other people, it is irresponsible not to share it. I'm a researcher, and the more I looked at this, the more questions I had. Make your own decisions. 

1) I don't like it when people bomb boards with "Scam!", "Toxic waste!", etc. without giving any further info or backing. (Same for "troll" or "basher") I presented my concerns and when asked for sources, I gave them. Never called it a scam, never said a bad word about Doug or questioned his qualifications. 

2) How could anyone know about the past sins of Tim? Dude, be serious. This is public information anyone with access to Google can find. Literally google "Timothy Shelburn Las Vegas" and it comes up. It's possible an actual private investigation would turn up worse. In any case, is it not our obligation as investors to do thorough due diligence on any company holding our investments? 

3) Who cares about Tim? Well, Tim is not "just anybody". He is the President of Collection Sites. And if the LinkedIn profile shared on here yesterday is to be believed, he is as of December 2020 COO of Medivolve. https://www.linkedin.com/in/tim-shelburn-6189151bb/
As far as "defamation" goes, as was said on CEO.ca, LOL, I'm not "defaming" him. Pointing out that yes, he was convicted of securities fraud and *implicated* in embezzlement is not defamation -- it's factual. I never said he was currently doing either with Medivolve. Some people don't care. Great. When investing my money, it makes me proceed with caution, because it signals this could be someone who is morally ambiguous when it comes to respecting securities law. 

4) Why did I look up Tim? I stumbled across this board based on a DD thread shared on Reddit I thought was quite good. I was browsing the board and noticed the back-and-forth with knowsbest. There was a post where s/he said "check the reviews". I hadn't done so, so I did, and I was bothered by it. It appears the problem is coming from Collection Sites. The last meeting featured Tim Shelburn as President of Collection Sites, so I decided to look him up to see what made him qualified to run that subsidiary. All stuff I *should* have done before investing. However, I didn't. 

4) I left my post yesterday wondering how Medivolve got involved with Shelburn. From his LinkedIn, I see he's affiliated with Forbes & Manhattan. This might be incredibly naive, but I have never in my life heard of Stan Bharti, the guy who funded QuestCap in 2020 AND put Doug Sommerville in as CEO. An hour of research put a lot of pieces of the puzzle together *for me*. 

5) Some people are convinced this is manipulation by Canaccord to get cheap shares before this stock rockets. It's possible. Does anyone have any evidence of Canaccord shorting any other stock they've invested in to get in as cheap as possible? 

I couldn't find any (I'm not saying it's not true), but what I DID find are ties from Stan Bharti/Forbes & Manhattan and Canaccord. More is out there, feel free to look it up if you'd like. 

https://www.globenewswire.com/news-release/2012/03/26/1432171/0/en/Forbes-Manhattan-Expands-Its-Footprint-into-the-United-Kingdom.html

[url=https://www.stockwatch.com/News/Item?bid=Z-C:AGG-2899079&symbol=AGG®ion=C]https://www.stockwatch.com/News/Item?bid=Z-C:AGG-2899079&symbol=AGG®ion=C[/url]

Scroll to Page 3, section [7]

6) Then, I found out that Forbes & Manhattan likes to seed companies, remove the directors, install their own people, and then acquire "businesses" head by other people involved with Forbes & Manhattan. Similar to how they acquired "Collection Sites" from affiliate Tim Shelburn. It will be interesting to see who the head of "Karland Health" is. I am willing to bet it will be someone affiliated with Forbes & Manhattan. If it is not, you have my word I will issue a public mea culpa across every single stock board. Once the company has been sufficiently pumped, big investors cash out. 
Some reading on what Bharti has done with past companies. Maybe you'll see some parallels, especially after what has happened with the sell-off. 

https://finance.yahoo.com/news/insiders-selling-black-iron-inc-162420358.html

https://stockhouse.com/companies/bullboard/t.aab/aberdeen-international-inc?postid=28230966

Mentions Scott Moore, too, who is now part of Medivolve

Link to Complaint about Bharti's Conflicts of Interest P. 8, section (c)

https://iknnews.com/we-can-track-a-few-of-the-inside-sellers-at-belo-sun-bsx-to/

https://iknnews.com/a-reminder-as-to-why-stan-bharti-is-poison-to-retail-shareholders/

**READ THROUGH THOSE BOARDS** Most were complaining about "shorters", "bashers", etc. Now they're "waiting for earnings" before deciding whether to jump ship. Sound familiar? Look at the price of the stocks. 

Aaron Atin, lawyer for Forbes & Manhattan and Secretary of Medivolve has cashed in and immediately sold off all of his positions in the company as of the 10th of February. 

https://www.canadianinsider.com/company-insider-filings?ticker=MEDV

I have zero idea if Canaccord and F&M are working together on this. But instead of *just* obsessing over who bought the 500,000 shares that went down yesterday, maybe you might want answers on who *sold* them and why? 

As shareholders, you guys deserve answers about what exactly is going on. I have my doubts that the "paper hands" email is legit (seriously unprofessional), but in any case, you deserve transparency. 

Hold, sell, do whatever you want. Just be informed about who is doing what with the money you're investing. Whether that's Medivolve, Canaccord or Forbes & Manhattan. Good luck to you guys. I sincerely hope it works out. 

<< Previous
Bullboard Posts
Next >>